| USWorld

Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Bayer, Reckitt among final contenders for Merck consumer health care unit

Daily Photo Galleries

By Reuters
Saturday, April 26, 2014, 8:57 p.m.

Merck & Co. Inc. is in the final stages of selling its consumer health care unit for nearly $14 billion, with Bayer AG and Reckitt Benckiser Group Plc among final contenders to clinch a deal as soon as this week, people familiar with the matter said.

Germany's Bayer and British consumer products giant Reckitt have emerged as front-runners to win the auction after each offering about $13.5 billion for the Merck consumer unit, best known for Coppertone sunscreen and Claritin allergy medicine, the sources said.

Both bidders are very keen to buy the asset, and the price tag could go higher in the final days, one person added. All the people asked not to be named because the matter is not public.

Representatives of American drugmaker Merck, as well as Bayer and Reckitt, declined to comment.



Show commenting policy

Most-Read Nation

  1. UCLA inundated by burst pipe
  2. Move over, Mickey, here comes Crayola
  3. Highway funding overhaul sought
  4. Lone clinic in Miss. for abortions still stands
  5. N.H. kidnapping suspect held on $1M bail
  6. Girl struck by plane on beach succumbs
  7. Obama’s many rules often violate statute
  8. Swift action expected of VA’s new secretary
  9. Met Museum of Art president to retire
  10. Appeals court upholds nation of origin labels for meat
  11. Surgeon general echoes warnings about skin cancer
Subscribe today! Click here for our subscription offers.